Virax Biolabs Group Limited Made Headway
Wed, Aug 14, 2024 at 07:13 PM
Virax Biolabs Group Limited (VRAX:NASDAQ) rocketted at $1.73, representing a gain of 35.2%. On Wed, Aug 14, 2024, VRAX:NASDAQ hit a New 2-Week High of $1.73. The stock got featured on our News Catalysts scanner on Mon, Aug 12, 2024 at 02:17 PM in the 'PUBLIC OFFERING' category. From Wed, Jul 31, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Jun 06, 2024 at $2.8 with a volume of 79M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Kubient Inc. (KBNT:NASDAQ), 100%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 100%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 81.89%
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 67.83%
- Digital Ally, Inc. (DGLY:NASDAQ), 61.73%
- Knightscope Inc. (KSCP:NASDAQ), 52.11%
- Reborn Coffee Inc. (REBN:NASDAQ), 35.36%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 35.16%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 34.03%
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 33.4%